Tg Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 2.34, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Tg Therapeutics Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 156 days, from 155 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 233 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1653, from overall ranking in the first quarter 2026 at 2851.

What is Receivable Turnover Ratio?
What is Tg Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TGTX Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	73.45 %	106.21 %	136.58 %	129.32 %	176.91 %
Y / Y Revenue Change	70.27 %	69.56 %	78 %	92.79 %	92.13 %
Receivable Turnover Ratio (TTM)	2.34	2.35	2.48	2.61	2.72
TGTX's Total Ranking	# 1653	# 2851	# 942	# 3023	# 2553
Accounts Receivable average collection period days	156	156	147	140	134
Seq. Receivable Change	2.43 %	28.28 %	15.16 %	14.63 %	21.77 %
Seq. Revenue Change	17.28 %	6.41 %	19.09 %	14.57 %	16.79 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 60
Healthcare Sector	# 234
Overall Market	# 1653

Receivable Turnover Ratio Statistics
High	Average	Low
0.97	0.18	0
(Jun 30 2024)		(Dec 31 2020)

TGTX Company Profile • Back to TGTX Efficiency Comparisons • Compare TGTX Receivables Turnover Ratio to its Competitors

Financial Statements
Tg Therapeutics Inc 's Accounts Receivable	$ 402 Millions	Visit TGTX's Balance sheet
Tg Therapeutics Inc 's Sales TTM	$ 800 Millions	Visit TGTX's Income Statement
Sources of TGTX's Revenues		Visit TGTX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
TGTX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
TGTX's Growth Rates	TGTX's Roa	TGTX's Inventory Turnover Ratio	TGTX's Dividend Comparisons
TGTX's Profitability Ratios	TGTX's Roi	TGTX's Asset Turnover Ratio	TGTX's Dividend Growth
TGTX's Valuation Ratios	TGTX's Roe	TGTX's Financial Strength Ratios	TGTX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Johnson and Johnson	5.47	$ 97,929.000 Millions	$ 17,889.000 Millions
Merck and Co Inc	5.47	$ 66,569.000 Millions	$ 12,167.250 Millions
Quanterix Corporation	5.45	$ 152.716 Millions	$ 28.030 Millions
Brightspring Health Services Inc	5.45	$ 5,877.918 Millions	$ 1,079.324 Millions
Charles River Laboratories International inc	5.44	$ 3,998.987 Millions	$ 734.654 Millions
Viskase Holdings inc	5.44	$ 177.054 Millions	$ 32.555 Millions
Emergent Biosolutions Inc	5.44	$ 770.200 Millions	$ 141.625 Millions
Ardelyx inc	5.44	$ 450.894 Millions	$ 82.913 Millions
Rigel Pharmaceuticals Inc	5.43	$ 276.785 Millions	$ 50.994 Millions
Blue Water Vaccines Inc	5.42	$ 0.646 Millions	$ 0.119 Millions
Sintx Technologies Inc	5.37	$ 1.330 Millions	$ 0.248 Millions
Igc Pharma Inc	5.36	$ 1.101 Millions	$ 0.206 Millions
Cytokinetics Incorporated	5.33	$ 67.670 Millions	$ 12.708 Millions
Strata Critical Medical Inc	5.27	$ 211.642 Millions	$ 40.126 Millions
Karyopharm Therapeutics Inc	5.27	$ 146.621 Millions	$ 27.821 Millions
Enovis Corp	5.21	$ 2,294.938 Millions	$ 440.151 Millions
The Cooper Companies Inc	5.20	$ 4,236.600 Millions	$ 814.025 Millions
Cryoport inc	5.19	$ 186.452 Millions	$ 35.933 Millions
Elutia Inc	5.16	$ 11.353 Millions	$ 2.198 Millions
Pluri Inc	5.15	$ 1.016 Millions	$ 0.197 Millions
Opus Genetics Inc	5.13	$ 9.856 Millions	$ 1.921 Millions
Carlsmed Inc	5.13	$ 62.457 Millions	$ 12.175 Millions
West Pharmaceutical Services Inc	5.12	$ 3,326.900 Millions	$ 649.250 Millions
Repligen Corp	5.09	$ 785.101 Millions	$ 154.205 Millions
Progyny Inc	5.09	$ 1,311.298 Millions	$ 257.570 Millions
Pacific Biosciences Of California Inc	5.04	$ 159.315 Millions	$ 31.630 Millions
Sarepta Therapeutics Inc	5.03	$ 1,974.344 Millions	$ 392.275 Millions
Amphastar Pharmaceuticals Inc	5.01	$ 730.019 Millions	$ 145.768 Millions
Zimmer Biomet Holdings Inc	5.00	$ 8,508.800 Millions	$ 1,700.200 Millions
Abbvie Inc	4.99	$ 64,386.000 Millions	$ 12,915.250 Millions

Date modified: 2026-09-09T22:26:19+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.